18F-fluorodeoxyglucose PET/CT as an independent predictor for patients with hepatocellular carcinoma combined with major portal vein tumor thrombus
Open Access
- 1 January 2020
- journal article
- research article
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 99 (1) , 8-17
Abstract
Hu XG, et al. Ann Surg Treat Res. 2020 Jul;99(1):8-17. https://doi.org/10.4174/astr.2020.99.1.8Keywords
This publication has 25 references indexed in Scilit:
- Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resectionHPB, 2012
- Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesisJournal of Hepatology, 2011
- Portal venous invasion: The single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2011
- Surgical Strategy for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Based on Prognostic FactorsJournal of Gastrointestinal Surgery, 2009
- Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Predicts Tumor Differentiation, P-glycoprotein Expression, and Outcome after Resection in Hepatocellular CarcinomaClinical Cancer Research, 2007
- Prognostic Index for Patients with Hepatocellular Carcinoma Combined with Tumor Thrombosis in the Major Portal VeinJournal of the American College of Surgeons, 2006
- Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter studySurgery, 2005
- Prognosis After Hepatic Resection for Stage IVA Hepatocellular CarcinomaAnnals of Surgery, 2003
- Natural history of inoperable hepatocellular carcinoma: Estrogen receptors’ status in the tumor is the strongest prognostic factor for survivalHepatology, 2000
- Natural History of Untreated Nonsurgical Hepatocellular Carcinoma: Rationale for the Design and Evaluation of Therapeutic TrialsHepatology, 1999